- Home
- ORGN vs NVCT Comparison
ORGN vs NVCT Comparison
Compare ORGN & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGN
- NVCT
- Stock Information
- Founded
- ORGN 2008
- NVCT 2020
- Country
- ORGN United States
- NVCT United States
- Employees
- ORGN N/A
- NVCT N/A
- Industry
- ORGN Major Chemicals
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- ORGN Industrials
- NVCT Health Care
- Exchange
- ORGN Nasdaq
- NVCT Nasdaq
- Market Cap
- ORGN 72.7M
- NVCT 184.9M
- IPO Year
- ORGN N/A
- NVCT 2022
- Fundamental
- Price
- ORGN $0.48
- NVCT $7.47
- Analyst Decision
- ORGN Strong Buy
- NVCT Strong Buy
- Analyst Count
- ORGN 1
- NVCT 3
- Target Price
- ORGN $3.00
- NVCT $17.00
- AVG Volume (30 Days)
- ORGN 785.1K
- NVCT 188.7K
- Earning Date
- ORGN 08-13-2025
- NVCT 08-05-2025
- Dividend Yield
- ORGN N/A
- NVCT N/A
- EPS Growth
- ORGN N/A
- NVCT N/A
- EPS
- ORGN N/A
- NVCT N/A
- Revenue
- ORGN $29,887,000.00
- NVCT N/A
- Revenue This Year
- ORGN $49.18
- NVCT N/A
- Revenue Next Year
- ORGN $144.81
- NVCT N/A
- P/E Ratio
- ORGN N/A
- NVCT N/A
- Revenue Growth
- ORGN N/A
- NVCT N/A
- 52 Week Low
- ORGN $0.40
- NVCT $4.44
- 52 Week High
- ORGN $1.90
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- ORGN 50.06
- NVCT 29.84
- Support Level
- ORGN $0.42
- NVCT $7.84
- Resistance Level
- ORGN $0.50
- NVCT $8.27
- Average True Range (ATR)
- ORGN 0.03
- NVCT 0.48
- MACD
- ORGN 0.01
- NVCT -0.09
- Stochastic Oscillator
- ORGN 81.03
- NVCT 5.18
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.